ChatGPT-Supported Text Messaging Program for Smoking Cessation
ConditionSmoking Cessation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGeorge Washington University
About this trial
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Eligibility criteria
Qualifiers
lives in the US
smoked a cigarette within the last 7 days
has a mobile phone
willing to receive text messages about the health effects of smoking on their mobile phone for 30 days
Disqualifiers
none
Trial design
Treatments tested in this trial
- BeFree+Bot
- BeFree
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov